Negative in Ames (Salmonella and E. coli), in vitro chromosome aberration and mouse micronucleus assays
“Aceclidine did not show any potential to cause genetic toxicity in a series of studies that included: 1) bacterial assays (Salmonella and E. coli) for reverse gene mutations; 2) an in vitro chromosome aberration assay in cultured human peripheral blood lymphocytes; and 3) an in vivo chromosome aberration assay (micronucleus test) in mice.”
Oral rat and rabbit EFD: no maternal toxicity, skeletal anomalies or reduced fetal weight at 1.5 mg/kg/day
“In embryofetal development studies, oral administration of aceclidine to pregnant rats and rabbits throughout organogenesis produced no maternal toxicity, skeletal anomalies, nor reduction in fetal body weight at 1.5 mg/kg/day”
Not conducted for QT; QT risk considered low given very limited systemic exposure
“QT prolongation Not studied. Given that systemic exposure to aceclidine in the proposed dosage is very limited, the risk of QT prolongation with ocular administration would be low.”
Not genotoxic overall: Ames negative; in vitro chromosome aberration positive without (not with) metabolic activation; rat micronucleus and comet negative